Evidence map›Paper›PMID 40588807›Full record

ArticleChinese medical journal2026

Survival outcomes of radical surgery after induction chemoimmunotherapy in clinical stage IIIA-IIIB (N2) non-small cell lung cancer.

Pengfei Li, Xin Wang, Miqi Gu, Kaili Huang, Long Tian, Jue Li, Qiang Wu, Ting Wang, Jintao He, Guowei Che and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Chinese medical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Pengfei LiDepartment of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
Xin WangLaboratory of Pulmonary Immunology and Inflammation, Frontiers Science Center for Disease-Related Molecular Network, Sichuan University, Chengdu, Sichuan 610041, China.
Miqi GuDepartment of Clinical Medicine, Southwest Medical University, Luzhou, Sichuan 646000, China.
Kaili HuangDepartment of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
Long TianDepartment of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
Jue LiLung Cancer Center/Lung Cancer Institute, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
Qiang WuLung Cancer Center/Lung Cancer Institute, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
Ting WangLung Cancer Center/Lung Cancer Institute, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
Jintao HeDepartment of Thoracic Surgery, Sichuan Cancer Hospital & Institute Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, Sichuan 610041, China.
Guowei CheDepartment of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
Qinghua ZhouDepartment of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40588807
PMCPMC13485927

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.